Sagimet Biosciences Inc.
SGMT
$6.15
$0.071.07%
NASDAQ
| 09/30/2025 | 06/30/2025 | ||||
|---|---|---|---|---|---|
| Revenue | -- | -- | |||
| Total Other Revenue | -- | -- | |||
| Total Revenue | -- | -- | |||
| Cost of Revenue | -- | -- | |||
| Gross Profit | -- | -- | |||
| SG&A Expenses | -1.56% | 3.40% | |||
| Depreciation & Amortization | -- | -- | |||
| Other Operating Expenses | -- | -- | |||
| Total Operating Expenses | 20.20% | -39.97% | |||
| Operating Income | -20.20% | 39.97% | |||
| Income Before Tax | -24.28% | 42.86% | |||
| Income Tax Expenses | -- | -- | |||
| Earnings from Continuing Operations | -24.28% | 42.86% | |||
| Earnings from Discontinued Operations | -- | -- | |||
| Extraordinary Item & Accounting Change | -- | -- | |||
| Minority Interest in Earnings | -- | -- | |||
| Net Income | -24.28% | 42.86% | |||
| EBIT | -20.20% | 39.97% | |||
| EBITDA | -- | -- | |||
| EPS Basic | -23.25% | 42.86% | |||
| Normalized Basic EPS | -23.26% | 42.86% | |||
| EPS Diluted | -23.25% | 42.86% | |||
| Normalized Diluted EPS | -23.26% | 42.86% | |||
| Average Basic Shares Outstanding | 0.84% | 0.00% | |||
| Average Diluted Shares Outstanding | 0.84% | 0.00% | |||
| Dividend Per Share | -- | -- | |||
| Payout Ratio | -- | -- | |||